Geoffrey E. Harris - Net Worth and Insider Trading
Geoffrey E. Harris Net Worth
The estimated net worth of Geoffrey E. Harris is at least $22,573 dollars as of 2024-11-10. Geoffrey E. Harris is the Director of Cancer Genetics Inc and owns about 4,250 shares of Cancer Genetics Inc (CGIX) stock worth over $19,593. Geoffrey E. Harris is the Director of Vyant Bio Inc and owns about 14,019 shares of Vyant Bio Inc (VYNT) stock worth over $2,720. Geoffrey E. Harris is also the Director of Emmaus Life Sciences Inc and owns about 8,685 shares of Emmaus Life Sciences Inc (EMMA) stock worth over $261. Details can be seen in Geoffrey E. Harris's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Geoffrey E. Harris has not made any transactions after 2022-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Geoffrey E. Harris
Geoffrey E. Harris Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Geoffrey E. Harris owns 4 companies in total, including Cancer Genetics Inc (CGIX) , Emmaus Life Sciences Inc (EMMA) , and American Caresource Holdings Inc (GNOW) among others .
Click here to see the complete history of Geoffrey E. Harris’s form 4 insider trades.
Insider Ownership Summary of Geoffrey E. Harris
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CGIX | Cancer Genetics Inc | 2019-07-23 | director |
| EMMA | Emmaus Life Sciences Inc | 2017-12-06 | director |
| GNOW | American Caresource Holdings Inc | 2015-08-28 | director |
 | | 2022-11-18 | director |
Geoffrey E. Harris Latest Holdings Summary
Geoffrey E. Harris currently owns a total of 3 stocks. Among these stocks, Geoffrey E. Harris owns 4,250 shares of Cancer Genetics Inc (CGIX) as of January 14, 2019, with a value of $19,593 and a weighting of 86.8%. Geoffrey E. Harris owns 14,019 shares of Vyant Bio Inc (VYNT) as of November 18, 2022, with a value of $2,720 and a weighting of 12.05%. Geoffrey E. Harris also owns 8,685 shares of Emmaus Life Sciences Inc (EMMA) as of December 6, 2017, with a value of $261 and a weighting of 1.15%.
Latest Holdings of Geoffrey E. Harris
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CGIX | Cancer Genetics Inc | 2019-01-14 | 4,250 | 4.61 | 19,593 |
| VYNT | Vyant Bio Inc | 2022-11-18 | 14,019 | 0.19 | 2,720 |
| EMMA | Emmaus Life Sciences Inc | 2017-12-06 | 8,685 | 0.03 | 261 |
Holding Weightings of Geoffrey E. Harris
Geoffrey E. Harris Form 4 Trading Tracker
According to the SEC Form 4 filings, Geoffrey E. Harris has made a total of 0 transactions in Cancer Genetics Inc (CGIX) over the past 5 years. The most-recent trade in Cancer Genetics Inc is the acquisition of 3,333 shares on January 14, 2019, which cost Geoffrey E. Harris around $23,000.
According to the SEC Form 4 filings, Geoffrey E. Harris has made a total of 1 transactions in Vyant Bio Inc (VYNT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Vyant Bio Inc is the sale of 765 shares on November 18, 2022, which brought Geoffrey E. Harris around $1,017.
According to the SEC Form 4 filings, Geoffrey E. Harris has made a total of 0 transactions in Emmaus Life Sciences Inc (EMMA) over the past 5 years. The most-recent trade in Emmaus Life Sciences Inc is the acquisition of 759 shares on December 6, 2017, which cost Geoffrey E. Harris around $17,343.
Insider Trading History of Geoffrey E. Harris
- 1
Geoffrey E. Harris Trading Performance
GuruFocus tracks the stock performance after each of Geoffrey E. Harris's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Geoffrey E. Harris is 5.82%. GuruFocus also compares Geoffrey E. Harris's trading performance to market benchmark return within the same time period. The performance of stocks bought by Geoffrey E. Harris within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Geoffrey E. Harris's insider trading performs compared to the benchmark.
Performance of Geoffrey E. Harris
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.52 | | | | | |
| Relative Return to S&P 500(%) | -1.11 | | | | | |
Geoffrey E. Harris Ownership Network
Ownership Network List of Geoffrey E. Harris
Ownership Network Relation of Geoffrey E. Harris
Geoffrey E. Harris Owned Company Details
What does Cancer Genetics Inc do?
Who are the key executives at Cancer Genetics Inc?
Geoffrey E. Harris is the director of Cancer Genetics Inc. Other key executives at Cancer Genetics Inc include President & Discovery Services Ralf Brandt , Chief Financial Officer Michael Glenn Miles , and Chief Executive Officer John A Roberts .
Cancer Genetics Inc (CGIX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cancer Genetics Inc (CGIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cancer Genetics Inc (CGIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cancer Genetics Inc (CGIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cancer Genetics Inc Insider Transactions
Geoffrey E. Harris Mailing Address
Above is the net worth, insider trading, and ownership report for Geoffrey E. Harris. You might contact Geoffrey E. Harris via mailing address: 8 Hartley Farms Road, Morristown Nj 07960.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
